Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert consensus on the use of omalizumab in chronic urticaria in China.
Zhao Z, Cai T, Chen H, Chen L, Chen Y, Gao X, Gao X, Geng S, Guo Y, Hao F, Hao G, Hu Y, Jin H, Jin Z, Li C, Li H, Li J, Li Y, Liang Y, Liu G, Liu Q, Long H, Ma L, Shang Y, Song Y, Song Z, Su X, Sui H, Sun Q, Sun Y, Tang J, Tong X, Wang H, Wang G, Wang L, Wang S, Xiang L, Xiao T, Xie Z, Ye L, Yu Y, Zhang C, Zhang L, Zhang S, Zheng R, Zhi L, Zhou W, Zou Y, Maurer M. Zhao Z, et al. Among authors: zhang l, zhang c, zhang s. World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34934470 Free PMC article. Review.
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.
Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Tao J, Xie L, Wang Y, Wang J, Wang G. Yu C, et al. Among authors: zhang c, zhang f. Int Immunopharmacol. 2022 Nov;112:109248. doi: 10.1016/j.intimp.2022.109248. Epub 2022 Sep 18. Int Immunopharmacol. 2022. PMID: 36126411 Clinical Trial.
Visit Adherence of Mild to Moderate Psoriasis Patients: A Mobile-Based Randomized Study.
Zhao Y, Wang G, Ni W, Song Z, Chen K, Zhang C, Zhang S, Ding Y, Zheng M, Shi Y, Lin Z, Liu X, Zhang X, Zhou Q, Ahmed KD. Zhao Y, et al. Among authors: zhang c, zhang s, zhang x. Patient Prefer Adherence. 2021 Jan 5;14:2551-2557. doi: 10.2147/PPA.S277103. eCollection 2020. Patient Prefer Adherence. 2021. PMID: 33447016 Free PMC article.
Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
Yuan W, Hu S, Li M, Yang L, Liu L, Zheng M, Guo Z, Song Z, Zhang C, Diao Q, Xu J, Richard A, Patwardhan M, Lyu T, Uddin A, Fogel R, Ligueros-Saylan M, Zheng J. Yuan W, et al. Among authors: zhang c. Dermatol Ther. 2022 Apr;35(4):e15303. doi: 10.1111/dth.15303. Epub 2022 Jan 17. Dermatol Ther. 2022. PMID: 34984792 Free PMC article. Clinical Trial.
Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition).
Shi L, Wang H, Chen K, Yan J, Yu B, Wang S, Yin R, Nong X, Zou X, Chen Z, Li C, Chen L, Zhang C, Zhang F, Zheng H, Zheng M, Tu P, Xu J, Tao J, Kang X, Zeng K, Lu Y, Yu N, Lei X, Pan M, Ju Q, Gu H, Wang X. Shi L, et al. Among authors: zhang c, zhang f. Photodiagnosis Photodyn Ther. 2021 Sep;35:102340. doi: 10.1016/j.pdpdt.2021.102340. Epub 2021 May 12. Photodiagnosis Photodyn Ther. 2021. PMID: 33991660 Review.
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis.
Zhang C, Yan K, Diao Q, Guo Q, Jin H, Yang S, Chen X, Lei T, Wu J, Yu H, Zheng M, Gao X, Sinclair R, Zhu Y, Xu Q, Xu J. Zhang C, et al. J Am Acad Dermatol. 2022 Jul;87(1):95-102. doi: 10.1016/j.jaad.2022.01.005. Epub 2022 Jan 10. J Am Acad Dermatol. 2022. PMID: 35026342 Clinical Trial.
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
Liu L, Zhang C, Wang J, Chen K, Ding Y, Yan G, Lu Q, Li W, Fang H, Cheng H, Zhang J, He Y, Zhu W, Lu Y, Huang J, Pan W, Li M, Cao S, Li S, Han X, He L, Chen Y, Zheng M. Liu L, et al. Among authors: zhang c, zhang j. Eur J Dermatol. 2020 Oct 1;30(5):580-590. doi: 10.1684/ejd.2020.3876. Eur J Dermatol. 2020. PMID: 33052103 Clinical Trial.
68,579 results
You have reached the last available page of results. Please see the User Guide for more information.